scispace - formally typeset
Search or ask a question
Topic

Epworth Sleepiness Scale

About: Epworth Sleepiness Scale is a research topic. Over the lifetime, 4742 publications have been published within this topic receiving 155088 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: Even apart from its association with impaired cognition, daytime sleepiness was associated with functional impairment in AD patients and its presence may be associated with greater impairment in instrumental activities and may warrant intervention.
Abstract: Objective Daytime sleep has been noted to accompany dementing illness and is more pronounced as dementia severity increases. Although acknowledged by caregivers, sleepiness during the daytime is among the least troublesome of sleep behaviors described in Alzheimer Disease (AD) patients. The purpose of this study was to examine whether patient and spouse/caregiver reports of daytime sleepiness in AD were associated with lower functional status in those patients. Methods The authors utilized the Epworth Sleepiness Scale to assess reported daytime sleepiness and a modification of the Lawton and Brody scale to assess functional status in a group of 137 AD patients. The authors also examined typical bedtimes and wakeup times via questionnaire. Results Higher levels of daytime sleepiness were associated with greater impairments in functional status. These results were independent of level of cognitive impairment, as assessed with Mini-Mental State Exam, and they were also detectable when the authors limited analyses to data reported only by spouse/caregiver. Findings were not associated with medication use. AD patients also had earlier bedtimes and later wake-up times than a comparison group. Conclusion Even apart from its association with impaired cognition, daytime sleepiness was associated with functional impairment in AD patients. Although daytime sleep may represent a welcome relief for caregivers, its presence may be associated with greater impairment in instrumental activities and may warrant intervention.

77 citations

Journal ArticleDOI
TL;DR: Assessment of insomnia may be important in the comprehensive care of epilepsy and may influence control of epileptic seizures.

77 citations

Journal ArticleDOI
TL;DR: In this paper, the role of sleep-related factors, ethnicity and socioeconomic deprivation in self-reported motor vehicle accidents while driving, after controlling for gender, age and driving exposure was assessed.

76 citations

Journal ArticleDOI
TL;DR: Adapted CBT produced greater and sustained improvements in sleep, daily fatigue levels, and depression compared with TAU, suggesting that CBT is a promising treatment for sleep disturbance and fatigue after TBI.

76 citations

01 Jan 2010
TL;DR: EDS, which can sometimes be severe, is common in PD patients even in the absence of SOREM and detectable CSF-hypocretin deficiency, and the determinants of which include severity of PD, wearing-off symptoms, dosage of antiparkinsonian drugs and sleep-disordered breathing.
Abstract: Background/Aims: Excessive daytime sleepiness (EDS) is frequent in patients with Parkinson’s disease (PD) Occasionally, EDS in PD exhibits narcolepsy-like features We aimed to assess characteristics and determinants of EDS in consecutive patients with PD Methods: Thirty consecutive patients with PD underwent a detailed clinical examination EDS was assessed using the Epworth Sleepiness Scale (ESS) and Multiple Sleep Latency Test (MSLT) Sleep was assessed using video-polysomnography Cerebrospinal fluid (CSF) hypocretin-1 levels were obtained in 3 patients Results: ESS was 1 10 in 17 patients (57%) Mean sleep latency (MSL) on MSLT was ! 5 min in 11 patients (37%) There was a significant negative correlation between ESS and MSL None of the 11 patients with MSL ! 5 min showed a sleep onset REM (SOREM) episode Patients with EDS had higher dopamine agonists/levodopa equivalent doses, higher apnea/hypopnea index and exhibited wearing-off symptoms more often Hypocretin-1 was normal in 3 patients tested Conclusion: EDS, which can sometimes be severe, is common in PD patients even in the absence of SOREM and detectable CSF-hypocretin deficiency In PD, EDS is a multifaceted phenomenon, the deterReceived: April 22, 2009 Accepted: October 18, 2009 Published online: January 16, 2010 Claudio L Bassetti, MD Neurocenter (EOC) of Southern Switzerland Neurology Department, Ospedale Civico, Via Tesserete 46 CH-6903 Lugano (Switzerland) Tel +41 91 811 6658, Fax +41 91 811 6915, E-Mail claudiobassetti @ eocch © 2010 S Karger AG, Basel 0014–3022/10/0633–0129$2600/0 Accessible online at: wwwkargercom/ene D ow nl oa de d by : 15 7 55 3 9 21 2 9/ 24 /2 01 6 6: 13 :3 0 A M

76 citations


Network Information
Related Topics (5)
Placebo
43K papers, 2.5M citations
76% related
Prospective cohort study
38.5K papers, 1.8M citations
75% related
Cohort
58.4K papers, 2M citations
74% related
Anxiety
141.1K papers, 4.7M citations
74% related
Odds ratio
68.7K papers, 3M citations
74% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
2023348
2022689
2021370
2020367
2019356
2018319